Article
Inhibition of angiogenesis and the angiogenesis/invasion shift
21 Nov 2011
Abstract excerpt
Angiogenesis has become a major target in cancer therapy. However, current therapeutic strategies have their limitations and raise several problems. In most tumours, anti-angiogenesis treatment targeting VEGF (vascular endothelial growth factor) has only limited overall survival benefit compared with conventional chemotherapy alone, and reveals several specific forms of resistance to anti-VEGF treatment. There is...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
